Abstract Background Pregnancy and the postpartum period constitute a high-risk window for the emergence of depressive symptoms. Peripartum depression (PPD) affects around 17% of women worldwide [1] and remains substantially underdetected, with clinically meaningful consequences for maternal functioning, mother-infant b...
B. Vai, L. Fortaner-Uyà, M. Shahisavandi et al.· International Journal of Neu...· 0 citations
This most comprehensive assessment of epigenetic and brain age models across development is provided, evaluating how these models associate with chronological age and with each other, and how these associations change across development.
Marlene Staginnus, V. Baltramonaityte, I. Schuurmans et al.· bioRxiv· 0 citations
It was found that maternal sleep and depressive symptoms were both stable over time and Infant sleep latency may represent a potential modifiable factor within this cycle.
F. Mao, H. El Marroun, S. J. Hoepel et al.· medRxiv· 0 citations
Most MPSs are better characterised as research tools at an early stage of development rather than clinical tools, and are highlighted as research tools at an early stage of development rather than clinical tools.
I. Schuurmans, S. Defina, A. P. C. Hermans et al.· The Lancet Child & Adolescen...· 0 citations
Background. Cord blood DNA methylation profile scores (MPSs) based on genetic and pre-/perinatal risk factors for neurodevelopmental conditions (NDCs) may capture downstream biological effects and help understand how combined exposure signals contribute to NDC risk. Methods. Using data from two longitudinal birth cohor...
Elena Isaevska, Rosa H. Mulder, I. Schuurmans et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
